Groups

Research Focus

Graduate Staff; Fellow

Recent additions – View all

1. Cost-effectiveness of Enasidenib versus conventional care for older patients with IDH2-mutant refractory/relapsed AML

   Journal Article

   Alhajahjeh, A.; Patel, K. K.; Shallis, R. M.; Podoltsev, N. A.; Kewan, T.; Stempel, J. M.; Mendez, L.; Huntington, S. F.; Stahl, M.; Goshua, G.; more...
   Leukemia and Lymphoma (2025)

   Fulltext@MSK | Save